Empirical Amphotericin B therapy on Day 4 or Day 8 of Febrile Neutropenia

Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study

(2012) G. Maschmeyer et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project

(2011) L. Pagano et al.   HAEMATOLOGICA

Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

(2009) Catherine Cordonnier et al.   CLINICAL INFECTIOUS DISEASES

Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management

(2008) O. Penack et al.   ANNALS OF ONCOLOGY

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT

(2008) H Hebart et al.   BONE MARROW TRANSPLANTATION

Patients at High Risk of Invasive Fungal Infections

(2008) Maria J G T Rüping et al.   DRUGS

Antifungal treatment strategies in high risk patients

(2008) Maria J. G. T. Rüping et al.   MYCOSES